BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20206689)

  • 1. Differences in RNA processing underlie the tissue specific phenotype of ISCU myopathy.
    Sanaker PS; Toompuu M; Hogan VE; He L; Tzoulis C; Chrzanowska-Lightowlers ZM; Taylor RW; Bindoff LA
    Biochim Biophys Acta; 2010 Jun; 1802(6):539-44. PubMed ID: 20206689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The High Level of Aberrant Splicing of ISCU in Slow-Twitch Muscle May Involve the Splicing Factor SRSF3.
    Rawcliffe DF; Österman L; Lindsten H; Holmberg M
    PLoS One; 2016; 11(10):e0165453. PubMed ID: 27783661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific splicing of ISCU results in a skeletal muscle phenotype in myopathy with lactic acidosis, while complete loss of ISCU results in early embryonic death in mice.
    Nordin A; Larsson E; Thornell LE; Holmberg M
    Hum Genet; 2011 Apr; 129(4):371-8. PubMed ID: 21165651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestation and a new ISCU mutation in iron-sulphur cluster deficiency myopathy.
    Kollberg G; Tulinius M; Melberg A; Darin N; Andersen O; Holmgren D; Oldfors A; Holme E
    Brain; 2009 Aug; 132(Pt 8):2170-9. PubMed ID: 19567699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue specificity of a human mitochondrial disease: differentiation-enhanced mis-splicing of the Fe-S scaffold gene ISCU renders patient cells more sensitive to oxidative stress in ISCU myopathy.
    Crooks DR; Jeong SY; Tong WH; Ghosh MC; Olivierre H; Haller RG; Rouault TA
    J Biol Chem; 2012 Nov; 287(48):40119-30. PubMed ID: 23035118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myopathy with lactic acidosis is linked to chromosome 12q23.3-24.11 and caused by an intron mutation in the ISCU gene resulting in a splicing defect.
    Olsson A; Lind L; Thornell LE; Holmberg M
    Hum Mol Genet; 2008 Jun; 17(11):1666-72. PubMed ID: 18296749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotide therapeutics for iron-sulphur cluster deficiency myopathy.
    Kollberg G; Holme E
    Neuromuscul Disord; 2009 Dec; 19(12):833-6. PubMed ID: 19846308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTBP1 acts as a dominant repressor of the aberrant tissue-specific splicing of ISCU in hereditary myopathy with lactic acidosis.
    Rawcliffe DFR; Österman L; Nordin A; Holmberg M
    Mol Genet Genomic Med; 2018 Nov; 6(6):887-897. PubMed ID: 30209894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intolerance.
    Mochel F; Knight MA; Tong WH; Hernandez D; Ayyad K; Taivassalo T; Andersen PM; Singleton A; Rouault TA; Fischbeck KH; Haller RG
    Am J Hum Genet; 2008 Mar; 82(3):652-60. PubMed ID: 18304497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient restoration of succinate dehydrogenase activity after rhabdomyolysis in iron-sulphur cluster deficiency myopathy.
    Kollberg G; Melberg A; Holme E; Oldfors A
    Neuromuscul Disord; 2011 Feb; 21(2):115-20. PubMed ID: 21196119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligonucleotide corrects splice abnormality in hereditary myopathy with lactic acidosis.
    Sanaker PS; Toompuu M; McClorey G; Bindoff LA
    Gene; 2012 Feb; 494(2):231-6. PubMed ID: 22155317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel de novo dominant mutation in
    Legati A; Reyes A; Ceccatelli Berti C; Stehling O; Marchet S; Lamperti C; Ferrari A; Robinson AJ; Mühlenhoff U; Lill R; Zeviani M; Goffrini P; Ghezzi D
    J Med Genet; 2017 Dec; 54(12):815-824. PubMed ID: 29079705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of multiple cellular defects associated with a novel G50E iron-sulfur cluster scaffold protein (ISCU) mutation leads to development of mitochondrial myopathy.
    Saha PP; Kumar SKP; Srivastava S; Sinha D; Pareek G; D'Silva P
    J Biol Chem; 2014 Apr; 289(15):10359-10377. PubMed ID: 24573684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The defective splicing caused by the ISCU intron mutation in patients with myopathy with lactic acidosis is repressed by PTBP1 but can be derepressed by IGF2BP1.
    Nordin A; Larsson E; Holmberg M
    Hum Mutat; 2012 Mar; 33(3):467-70. PubMed ID: 22125086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines.
    Holmes-Hampton GP; Crooks DR; Haller RG; Guo S; Freier SM; Monia BP; Rouault TA
    Hum Mol Genet; 2016 Dec; 25(23):5178-5187. PubMed ID: 28007899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated FGF21 secretion, PGC-1α and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle.
    Crooks DR; Natarajan TG; Jeong SY; Chen C; Park SY; Huang H; Ghosh MC; Tong WH; Haller RG; Wu C; Rouault TA
    Hum Mol Genet; 2014 Jan; 23(1):24-39. PubMed ID: 23943793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitated transfer of IscU-[2Fe2S] clusters by chaperone-mediated ligand exchange.
    Bonomi F; Iametti S; Morleo A; Ta D; Vickery LE
    Biochemistry; 2011 Nov; 50(44):9641-50. PubMed ID: 21977977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome.
    Götz A; Isohanni P; Pihko H; Paetau A; Herva R; Saarenpää-Heikkilä O; Valanne L; Marjavaara S; Suomalainen A
    Brain; 2008 Nov; 131(Pt 11):2841-50. PubMed ID: 18819985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical characterization of iron-sulfur cluster assembly in the scaffold IscU of Escherichia coli.
    Wu G; Li L
    Biochemistry (Mosc); 2012 Feb; 77(2):135-42. PubMed ID: 22348472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of the iron-sulfur cluster assembly gene IBA57 causes severe myopathy and encephalopathy.
    Ajit Bolar N; Vanlander AV; Wilbrecht C; Van der Aa N; Smet J; De Paepe B; Vandeweyer G; Kooy F; Eyskens F; De Latter E; Delanghe G; Govaert P; Leroy JG; Loeys B; Lill R; Van Laer L; Van Coster R
    Hum Mol Genet; 2013 Jul; 22(13):2590-602. PubMed ID: 23462291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.